Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0AV1T
|
||||
| Former ID |
DNC013701
|
||||
| Drug Name |
N-(2-iodethyl)arachidonylamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529848] | ||
| Formula |
C22H36INO
|
||||
| Canonical SMILES |
CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCI
|
||||
| InChI |
1S/C22H36INO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15-
|
||||
| InChIKey |
KOHVJRAXSGONGW-DOFZRALJSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529848] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.